Company / PP&E per Share
Larimar Therapeutics, Inc. PP&E per Share History
FY2014-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.02
FY2019
5-year range
$0.01 / $0.04
FY2015-FY2019
Trend
+61.4%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E per Share returned to growth in FY2019 after 4 years of decline, reaching $0.02.
Based on SEC 10-K filings.
0.02 in FY2019 with a 5-year CAGR of -27.3%.
Improved from $0.02 to $0.02 over the past 2 years.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -3.2%
- 5-Year CAGR
- -27.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, pp&e per share increased 61.4% year-over-year.
- Peak pp&e per share was recorded in FY2014.
- Lowest pp&e per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.64 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $0.02 | +61.4% |
| FY2018 | $0.01 | -29.4% |
| FY2017 | $0.02 | -20.4% |
| FY2016 | $0.02 | -38.5% |
| FY2015 | $0.04 | -63.6% |
| FY2014 | $0.11 | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026